Should You Buy, Sell, or Hold ISRG Stock at $585?

Preview

Considering the current context and the provided information, here is a detailed analysis of whether to buy, sell, or hold Intuitive Surgical (ISRG) stock at $585 as of January 2025:

Current Stock Performance and Market Sentiment

Recent Stock Performance: Intuitive Surgical's stock has shown significant growth over the past year, with a 62% increase during the 12-month period ending January 22, 2025. However, the stock has recently experienced some pullback, which can be attributed to the company's 2025 guidance being slightly below estimates.
Analyst Recommendations: Bernstein maintains an "Outperform" rating on Intuitive Surgical with a target price of $700. Additionally, 40 Wall Street analysts have given Intuitive Surgical an average rating of "Buy" with a price prediction of $514.94 for 2025. The consensus EPS estimates for the current quarter are $1.74, with a positive trend in earnings expectations over the past few weeks.
Market Activity: The stock closed at $573.48 on January 27, 2025, with a trading volume of 2,409,983. The stock price has been fluctuating around the $585 mark, indicating a stable but cautious market sentiment.

Financial Health and Future Outlook

Revenue and Earnings: Intuitive Surgical reported unaudited preliminary results for the fourth quarter of 2024 and provided guidance for 2025. The company is expected to post impressive earnings, ranking 6th on a list of stocks with strong earnings potential this week. The average revenue forecast for 2025 is approximately $3.395 trillion, with a low estimate of $3.334 trillion.
Brokerage Recommendations: The average brokerage recommendation for Intuitive Surgical is 1.59 on a scale of 1 to 5, indicating a strong buy sentiment among analysts.

Conclusion

Given the recent stock performance, analyst recommendations, and the company's strong financial health and future outlook, the consensus leans towards buying Intuitive Surgical stock at $585. The stock is currently trading below the target prices set by several analysts, indicating potential for growth. However, the slight pullback due to guidance being below estimates warrants caution. Therefore, a prudent strategy would be to Buy Intuitive Surgical stock at $585, keeping an eye on market trends and any further guidance from the company.

Should You Buy, Sell, or Hold ISRG Stock at $585?

Preview

Considering the current context and the provided information, here is a detailed analysis of whether to buy, sell, or hold Intuitive Surgical (ISRG) stock at $585 as of January 2025:

Current Stock Performance and Market Sentiment

Recent Stock Performance: Intuitive Surgical's stock has shown significant growth over the past year, with a 62% increase during the 12-month period ending January 22, 2025. However, the stock has recently experienced some pullback, which can be attributed to the company's 2025 guidance being slightly below estimates.
Analyst Recommendations: Bernstein maintains an "Outperform" rating on Intuitive Surgical with a target price of $700. Additionally, 40 Wall Street analysts have given Intuitive Surgical an average rating of "Buy" with a price prediction of $514.94 for 2025. The consensus EPS estimates for the current quarter are $1.74, with a positive trend in earnings expectations over the past few weeks.
Market Activity: The stock closed at $573.48 on January 27, 2025, with a trading volume of 2,409,983. The stock price has been fluctuating around the $585 mark, indicating a stable but cautious market sentiment.

Financial Health and Future Outlook

Revenue and Earnings: Intuitive Surgical reported unaudited preliminary results for the fourth quarter of 2024 and provided guidance for 2025. The company is expected to post impressive earnings, ranking 6th on a list of stocks with strong earnings potential this week. The average revenue forecast for 2025 is approximately $3.395 trillion, with a low estimate of $3.334 trillion.
Brokerage Recommendations: The average brokerage recommendation for Intuitive Surgical is 1.59 on a scale of 1 to 5, indicating a strong buy sentiment among analysts.